Two dollars. That is what a Delaware jury awarded Qualcomm this week in its legal fight with Arm. Yes, that is not a typo, and no, the number is not the point of the story. Behind the smallest damages award in recent chip industry memory sits a case that could decide billions in royalties and reshape how chip designs are licensed across the world.
Here is what the jury decided, why both companies are calling it a win, and what the ruling could eventually do to the price of your next smartphone.
What the Delaware jury actually decided
The verdict landed on October 13, according to a Reuters report, wrapping up the trial phase of Qualcomm’s lawsuit against Arm. The jury did not give a clean win to either side. It split the verdict eight ways:
- For Qualcomm, two counts. The jury found that Arm breached its obligation to provide software patches and tools for designs it licensed to Qualcomm. It also agreed that Arm intentionally interfered with Qualcomm’s relationship with Meta.
- For Arm, five counts. The jury sided with Arm on the remaining claims, so Arm walks away with the larger share of the verdict.
- For Qualcomm, two dollars. The damages award on Qualcomm’s counts totals $2. The symbolic figure suggests the jury saw a rights violation more than a money problem.
Unsurprisingly, both companies declared victory. Qualcomm got its finding that Arm acted wrongly. Arm got the majority of the counts. The real money question has not been decided yet.
Why the $2 award matters more than it looks
In US civil trials, a jury can find that a party was wronged without putting a large number on the damages. The two-dollar award signals that Qualcomm’s main goal was never a payout. It was a legal finding, and that finding carries weight:
- It validates the license Qualcomm already holds. Qualcomm had an architecture licensing agreement (ALA) with Arm long before it bought Nuvia in 2021. The verdict supports the view that using Nuvia’s know-how to design CPU cores was covered by that existing agreement.
- It pushes back on double licensing. The ruling establishes that companies with existing licenses do not have to pay duplicate licensing fees just because they acquire another company to strengthen their chip efforts.
- The Meta count is unusual. A finding that Arm interfered with Qualcomm’s relations with Meta adds an element of misconduct to Arm’s conduct, which matters beyond the damages line.
For chip designers everywhere, that middle point is the headline. Acquisitions are one of the main ways semiconductor companies grow, and the idea that buying a startup could trigger a fresh round of licensing fees to Arm was a real fear. This verdict eases it.
How the Qualcomm and Arm fight started
The dispute has roots going back to 2021, when Qualcomm acquired Nuvia, a chip design startup founded by former Apple engineers. Nuvia had its own Arm licenses and was working on high-performance CPU cores. Qualcomm planned to fold those designs into its Snapdragon lineup.
The promise was simple. Nuvia’s core designs were meant to close the performance gap with Apple’s custom silicon and reduce Qualcomm’s reliance on Arm’s standard Cortex blueprints. Arm’s position threatened that entire roadmap.
Arm took the position that Nuvia’s licenses did not simply transfer to Qualcomm. It threatened to cancel Qualcomm’s architecture licensing agreement, and Qualcomm went to court. Since then, the two companies have fought across multiple lawsuits and countersuits on several issues, with licensing fees for custom CPU cores as the central battlefield.
The trial that just ended was Qualcomm’s latest suit against Arm. The jury’s mixed verdict resolves the trial stage but leaves the biggest question open, and that question now sits with a federal judge.
The next stage: billions hang on one judge
The case moves to US District Judge Maryellen Noreika, who will resolve several remaining issues. Her decision could go in a direction that dwarfs the two-dollar award:
- Royalties could stop for five years. Judge Noreika could rule that Qualcomm does not have to pay royalties to Arm for five years. Industry watchers put the potential loss for Arm in the billions of dollars.
- Or royalties could continue. If the judge rules the other way, Qualcomm keeps paying, and those costs flow into chip economics.
- Chip prices follow the ruling. Licensing fees are part of what a Snapdragon chip costs to make. If Qualcomm pays more to Arm, that cost tends to travel downstream to phone makers and eventually to buyers.
Arm’s business model depends on licensing revenue from nearly every mobile chip in the world. A five-year royalty holiday for one of its biggest customers would dent its finances and could encourage other licensees to renegotiate. That is why the next ruling matters far more than the verdict this week.
What this means for smartphone buyers in India
India is one of the largest markets for Snapdragon-powered phones, from budget models to flagships. A few practical points:
- Do not expect immediate price changes. The verdict itself changes nothing at checkout this month. Chip pricing adjusts over product cycles, not overnight.
- Watch the 2027 flagships. If royalty costs shift after Judge Noreika’s ruling, the effect will show up in the bill of materials of phones launching after that, not in today’s stock.
- Custom cores matter to you. The Nuvia-derived CPU cores are already part of Qualcomm’s performance story. This case decides how freely Qualcomm can keep developing that technology.
- Competition keeps prices honest. MediaTek’s strong mid-range lineup gives phone makers alternatives, which limits how far any single chip vendor can push prices.
Why tech companies are watching this case
Beyond Qualcomm and Arm, this verdict sets a reference point for the industry:
- Acquisitions and licenses. If you own an Arm license and buy a startup with its own license, this case supports the idea that you are not automatically due for a second round of fees.
- Contract scope over brand power. The jury weighed written obligations, like providing software patches and tools for licensed designs, not just market positions.
- Precedent builds slowly. One Delaware verdict does not end licensing disputes forever, but it gives future negotiators something concrete to cite.
The chip industry runs on a web of cross-licenses, patent pools, and architecture agreements. Cases like this one, where a court actually interprets the deals instead of the companies settling quietly, are rare and valuable.
FAQ
Why did the jury award Qualcomm only $2?
The jury found that Arm breached its licensing obligations and interfered with Qualcomm’s relations with Meta, but it did not attach large monetary damages to those findings. The two-dollar award is symbolic. Qualcomm’s real prize is the legal ruling itself.
Did Qualcomm or Arm win the trial?
Both sides claim victory. Qualcomm won two counts, including a breach-of-contract finding, while Arm won five. The case now moves to a federal judge for decisions that could be worth far more than the verdict.
What happens next in the Qualcomm vs Arm case?
US District Judge Maryellen Noreika will resolve the remaining issues. She could rule that Qualcomm stops paying royalties to Arm for five years, a potential multi-billion-dollar hit to Arm, or require the payments to continue.
Will smartphone prices change because of this verdict?
Not right away. If the judge later changes Qualcomm’s royalty obligations, chip costs could shift and phone makers may pass some of that on over time. Current pricing is unaffected by this week’s verdict.
What was the Nuvia acquisition about?
Qualcomm bought Nuvia in 2021 to get custom CPU core designs for its Snapdragon chips. Arm argued those designs needed fresh licensing under Qualcomm, which sparked the lawsuits. This week’s verdict supports Qualcomm’s view that its existing agreement already covered the work.
